Ana Potic1, Bruce Nmezi2, Quasar S Padiath3. 1. Department of Neurology, Clinic for Child Neurology and Psychiatry, Medical Faculty University of Belgrade, 6A Dr. Subotica Street, Belgrade 11000, Serbia. Electronic address: a.potic@yahoo.com. 2. Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA 15261, USA. Electronic address: bcn6@pitt.edu. 3. Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA 15261, USA. Electronic address: qpadiath@pitt.edu.
Abstract
OBJECTIVE: Identification and characterization of a novel pedigree with ATP1A3 mutations presenting with CAPOS syndrome and hemiplegic migraine. METHODS: We have carried out clinical examinations of a three-generation pedigree with CAPOS syndrome and analyzed the ATP1A3 gene to identify causative mutations. The pedigree is of Slavic origin from Southeastern Europe. RESULTS: The clinical phenotype comprised cerebellar ataxia, areflexia, optic atrophy, and sensorineural hearing loss. Pes cavus was present in two of the four patients studied. The symptoms were triggered by fever and varied in severity in family members, exhibiting a chronic progressive course with or without relapses/remissions. The ATP1A3 c.2452G>A mutation was identified in the affected members of the family, while one of the mutation carriers exhibited both CAPOS and hemiplegic migraine. CONCLUSIONS: This study confirms that the specific c.2452G>A mutation in the ATP1A3 gene is associated with the CAPOS syndrome in pedigrees of different ethnic backgrounds. In patients with febrile episodes of ataxic encephalopathy or weakness, or both, genetic analysis of the ATP1A3 gene should be warranted. This is also the first report showing the co-occurrence of hemiplegic migraine and CAPOS syndrome in a patient with ATP1A3 mutations. Migraine has not been previously documented in ATP1A3 mutation carriers.
OBJECTIVE: Identification and characterization of a novel pedigree with ATP1A3 mutations presenting with CAPOS syndrome and hemiplegic migraine. METHODS: We have carried out clinical examinations of a three-generation pedigree with CAPOS syndrome and analyzed the ATP1A3 gene to identify causative mutations. The pedigree is of Slavic origin from Southeastern Europe. RESULTS: The clinical phenotype comprised cerebellar ataxia, areflexia, optic atrophy, and sensorineural hearing loss. Pes cavus was present in two of the four patients studied. The symptoms were triggered by fever and varied in severity in family members, exhibiting a chronic progressive course with or without relapses/remissions. The ATP1A3 c.2452G>A mutation was identified in the affected members of the family, while one of the mutation carriers exhibited both CAPOS and hemiplegic migraine. CONCLUSIONS: This study confirms that the specific c.2452G>A mutation in the ATP1A3 gene is associated with the CAPOS syndrome in pedigrees of different ethnic backgrounds. In patients with febrile episodes of ataxic encephalopathy or weakness, or both, genetic analysis of the ATP1A3 gene should be warranted. This is also the first report showing the co-occurrence of hemiplegic migraine and CAPOS syndrome in a patient with ATP1A3 mutations. Migraine has not been previously documented in ATP1A3 mutation carriers.
Authors: Irene J Chang; Margaret P Adam; Suman Jayadev; Thomas D Bird; Niranjana Natarajan; Ian A Glass Journal: Am J Med Genet A Date: 2017-11-01 Impact factor: 2.802
Authors: Hendrik Rosewich; Matthew T Sweney; Suzanne DeBrosse; Kevin Ess; Laurie Ozelius; Eva Andermann; Frederick Andermann; Gene Andrasco; Alice Belgrade; Allison Brashear; Sharon Ciccodicola; Lynn Egan; Alfred L George; Aga Lewelt; Joshua Magelby; Mario Merida; Tara Newcomb; Vicky Platt; Dominic Poncelin; Sandra Reyna; Masayuki Sasaki; Marcio Sotero de Menezes; Kathleen Sweadner; Louis Viollet; Mary Zupanc; Kenneth Silver; Kathryn Swoboda Journal: Neurol Genet Date: 2017-03-02
Authors: Ida Stenshorne; Magnhild Rasmussen; Panagiotis Salvanos; Chantal M E Tallaksen; Laurence A Bindoff; Jeanette Koht Journal: Cerebellum Ataxias Date: 2019-02-08
Authors: Paula F Kinoshita; Jacqueline A Leite; Ana Maria M Orellana; Andrea R Vasconcelos; Luis E M Quintas; Elisa M Kawamoto; Cristoforo Scavone Journal: Front Physiol Date: 2016-06-02 Impact factor: 4.566